DK1976538T3 - Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre - Google Patents

Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre

Info

Publication number
DK1976538T3
DK1976538T3 DK06841087T DK06841087T DK1976538T3 DK 1976538 T3 DK1976538 T3 DK 1976538T3 DK 06841087 T DK06841087 T DK 06841087T DK 06841087 T DK06841087 T DK 06841087T DK 1976538 T3 DK1976538 T3 DK 1976538T3
Authority
DK
Denmark
Prior art keywords
acid
treatment
pharmaceutical formulation
hyaluronic acid
osteoarthritis containing
Prior art date
Application number
DK06841087T
Other languages
English (en)
Inventor
Sergio Rosini
Silvia Trasciatti
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Application granted granted Critical
Publication of DK1976538T3 publication Critical patent/DK1976538T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DK06841087T 2005-12-29 2006-12-21 Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre DK1976538T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002515A ITMI20052515A1 (it) 2005-12-29 2005-12-29 Formulazione farmaceutica per il trattamento della osteoartrite
PCT/EP2006/012367 WO2007073921A1 (en) 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Publications (1)

Publication Number Publication Date
DK1976538T3 true DK1976538T3 (da) 2010-01-11

Family

ID=36648609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06841087T DK1976538T3 (da) 2005-12-29 2006-12-21 Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre

Country Status (20)

Country Link
US (4) US20090042833A1 (da)
EP (1) EP1976538B1 (da)
JP (1) JP2009522218A (da)
KR (2) KR101470608B1 (da)
AT (1) ATE446763T1 (da)
AU (1) AU2006331019B2 (da)
CA (1) CA2646974C (da)
CY (1) CY1109541T1 (da)
DE (1) DE602006010111D1 (da)
DK (1) DK1976538T3 (da)
ES (1) ES2333615T3 (da)
IT (1) ITMI20052515A1 (da)
NO (1) NO340794B1 (da)
NZ (1) NZ569420A (da)
PL (1) PL1976538T3 (da)
PT (1) PT1976538E (da)
RU (1) RU2414908C2 (da)
SI (1) SI1976538T1 (da)
WO (1) WO2007073921A1 (da)
ZA (1) ZA200805598B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103260628B (zh) * 2010-10-07 2015-07-29 成功大学 透明质酸用于促进血管生成的用途
CN111773173B (zh) 2014-11-07 2024-03-22 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
KR101706642B1 (ko) 2015-02-04 2017-02-17 주식회사 엑소스템텍 연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
IT201600123773A1 (it) * 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
IT202100023894A1 (it) * 2021-09-16 2023-03-16 Professional Derma Sa Composizione per utilizzo in campo ortopedico
JP2024113337A (ja) * 2023-02-09 2024-08-22 国立大学法人九州大学 変形性関節症治療用医薬組成物及びキット
EP4450062A1 (en) * 2023-04-20 2024-10-23 Abiogen Pharma S.p.A. Composition for the treatment of osteoarthrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
JP2001253827A (ja) * 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法
KR100492110B1 (ko) * 2000-05-05 2005-06-02 에프. 호프만-라 로슈 아게 비스포스폰산 또는 그의 염을 포함하는 피하 투여용겔-유사 약학 조성물
WO2003099992A2 (en) * 2002-05-17 2003-12-04 Wyeth Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
KR100648515B1 (ko) * 2004-05-04 2006-11-27 (주)아모레퍼시픽 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제

Also Published As

Publication number Publication date
SI1976538T1 (sl) 2010-01-29
KR20080082657A (ko) 2008-09-11
US9943540B2 (en) 2018-04-17
US20090042833A1 (en) 2009-02-12
CA2646974A1 (en) 2007-07-05
ATE446763T1 (de) 2009-11-15
EP1976538B1 (en) 2009-10-28
RU2414908C2 (ru) 2011-03-27
ZA200805598B (en) 2009-11-25
EP1976538A1 (en) 2008-10-08
AU2006331019B2 (en) 2012-03-22
HK1123986A1 (en) 2009-07-03
ITMI20052515A1 (it) 2007-06-30
ES2333615T3 (es) 2010-02-24
PT1976538E (pt) 2009-12-07
PL1976538T3 (pl) 2010-03-31
CY1109541T1 (el) 2014-08-13
NO20082848L (no) 2008-08-27
RU2008126108A (ru) 2010-01-10
JP2009522218A (ja) 2009-06-11
DE602006010111D1 (de) 2009-12-10
WO2007073921A1 (en) 2007-07-05
CA2646974C (en) 2013-06-11
US20180185407A1 (en) 2018-07-05
AU2006331019A1 (en) 2007-07-05
US20200147126A1 (en) 2020-05-14
NZ569420A (en) 2010-05-28
KR20140107651A (ko) 2014-09-04
AU2006331019A2 (en) 2009-01-22
KR101470608B1 (ko) 2014-12-09
NO340794B1 (no) 2017-06-19
US20140371170A1 (en) 2014-12-18

Similar Documents

Publication Publication Date Title
EA201170772A1 (ru) Органические соединения
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
EA200870217A1 (ru) 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
MX2009004714A (es) Derivados de pirazol fusionado 3-aminocarbonilo sustituidos como moduladores de proteina cinasa.
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
CY1110813T1 (el) Χημικες ενωσεις
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
AR047928A1 (es) Derivados de tetrahidropiridoindol
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
WO2006086562A3 (en) Phenylazetidinone derivatives
HN2008000311A (es) Formas cristalinas de 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
EA201100691A1 (ru) Антагонисты рецепторов лизофосфатидной кислоты
CL2007001710A1 (es) Compuestos derivados de amino-pirazolopiridina sustituidos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como tumores, artritis reumatoide, enfermedades de crecimiento vascular desregulado, entre otras.
ATE553105T1 (de) Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
WO2008013987A3 (en) N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
TR200806298A2 (tr) Farmasötik formülasyon
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
CL2008003659A1 (es) Compuestos derivados de 6-(4-bencilpiperazin-1-il)pirimidin-4-ona, moduladores de la enzima estearoil-coa-desaturasa 1; procedimiento de preparacion; composicin farmaceutica; y uso en el tratamiento y profilaxis de la obesidad.